Table 1 The baseline demographic and clinical data in different groups
From: Association between cytokine profiles and lung injury in COVID-19 pneumonia
Overall (n = 106) | COVID-19 without pneumonia/Mild (n = 12) | COVID-19 with pneumonia(n = 94) | p –values | Moderate (n = 69) | Severe (n = 25) | p –values | |
|---|---|---|---|---|---|---|---|
Age, years | 52.75 ± 16.09 | 43.92 ± 13.73 | 53.87 ± 16.08 | 0.043 | 51.41 ± 15.77 | 60.68 ± 15.23 | 0.005 |
Male sex, n(%) | 53 (50.0) | 4 (33.3) | 49 (52.1) | 0.220 | 34 (49.3) | 15 (60.0) | 0.309 |
Coexisting disorder | |||||||
Any, n(%) | 25 (23.6) | 0 (0.0) | 25 (26.6) | 0.041 | 14 (20.3) | 11 (44.0) | 0.007 |
Hypertension, n(%) | 17 (16.0) | 0 (0.0) | 17 (18.1) | 0.108 | 9 (13.0) | 8 (32.0) | 0.028 |
Diabetes mellitus, n(%) | 13 (12.3) | 0 (0.0) | 13 (13.8) | 0.169 | 7 (10.1) | 6 (24.0) | 0.103 |
CHD, n (%) | 2 (1.9) | 0 (0.0) | 2 (2.1) | 1.000 | 1 (1.4) | 1 (4.0) | 0.578 |
COPD, n (%) | 1 (0.9) | 0 (0.0) | 1 (1.1) | 1.000 | 1 (1.4) | 0 (0.0) | 1.000 |
Symptoms | |||||||
Fever, n (%) | 56 (52.8) | 3 (25.0) | 53 (56.4) | 0.040 | 37 (53.6) | 16 (64.0) | 0.082 |
Cough, n (%) | 52 (49.1) | 5 (41.7) | 47 (50.0) | 0.587 | 34 (49.3) | 13 (52.0) | 0.839 |
Sputum production, n (%) | 14 (13.2) | 1 (8.3) | 13 (13.8) | 0.596 | 7 (10.1) | 6 (24.0) | 0.179 |
Fatigue, n (%) | 20 (18.9) | 0 (0.0) | 20 (21.3) | 0.076 | 13 (18.8) | 7 (28.0) | 0.124 |
Dyspnea, n (%) | 7 (6.6) | 0 (0.0) | 7 (7.4) | 0.328 | 3 (4.3) | 4 (16.0) | 0.097 |
Vital signs | |||||||
Temperature(°C) | 36.50 (36.30–36.80) | 36.50 (36.33–36.60) | 36.50 (36.30–36.83) | 0.270 | 36.50 (36.30–36.65) | 36.90 (36.60–37.70) | 0.001 |
Respiratory Rate | 20.00 (20.00–20.00) | 19.50 (19.00–20.00) | 20.00 (20.00–20.25) | 0.002 | 20.00 (20.00–20.00) | 20.00 (20.00–22.00) | 0.001 |
Heart Rate | 89.89 ± 13.29 | 93.17 ± 14.48 | 89.47 ± 13.15 | 0.366 | 88.94 ± 13.94 | 90.92 ± 10.80 | 0.545 |
SpO2 (%) | 98.00 (97.00–98.00) | 98.00 (97.25–99.00) | 98.00 (97.00–98.00) | 0.174 | 98.00 (97.00–99.00) | 96.00 (93.50–98.00) | < 0.001 |